"I've learned through my medical school rotations that financial incentives provided by pharmaceutical companies are not acceptable and should be restricted, but I see value in pharmaceutical sales representatives as useful sources for information about a new drug, including data from clinical trials, samples for my future patients, and information about the manufacturer's program. This can make their drugs more affordable for patients who struggle financially, particularly those who don't have health insurance. Does your institution have any policies on working with pharmaceutical representatives? How do your urology residents typically interact with them?"